Q3 2025 Management View CEO Joseph Dowling opened the call by stating, "We are pleased with our progress as we move closer to ...
MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
After years of construction and millions of dollars, the long-awaited CV Link is officially open — a 40-mile path stretching ...
Semaglutide therapy was associated with higher likelihood of passing low-risk cardiovascular thresholds among patients with ...
Oral semaglutide 25 mg was associated with improved glycemic parameters and cardiovascular risk across weight loss categories ...
The Palm Springs Post on MSN
CV Link ribbon cuttings celebrate completion of 40-mile path; some work still to be done in Palm Springs
With the CV Link now officially open, attention turns to the creation of community connectors and improving bike ...
Following the approvals from exchanges, Tata Motors had informed in an exchange filing this week that its CV business will ...
The new entity, Tata Motors Ltd (CV), will be India’s largest commercial vehicle manufacturer, with a wide portfolio spanning ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback